Glacier Bancorp (GBCI) to Consolidate 11 Units into Single Bank
Tweet Send to a FriendGet Alerts GBCI Hot Sheet
Price: $19.78 +1.44%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.1%
EPS Growth %: +26.1%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.1%
EPS Growth %: +26.1%
Trade GBCI Now!
Glacier Bancorp, Inc. (Nasdaq: GBCI) plans to combine its eleven banking subsidiaries into a single commercial bank. The bank subsidiaries, which operate in the states of Montana, Colorado, Idaho, Utah, Washington and Wyoming, will operate as separate divisions of Glacier Bank under the same names, management teams and division directors as before the consolidation. Following the consolidation, Glacier Bank will have $7.2 billion in assets and through its divisions will operate 102 branches.
As part of this consolidation, Glacier Bank will file with the appropriate federal and state bank regulators an application to merge the bank subsidiaries. The resulting bank Board of Directors and executive officers will be the Board of Directors and senior management team of Glacier Bancorp. The consolidation is expected to be completed in early second quarter of 2012, following regulatory approvals.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
As part of this consolidation, Glacier Bank will file with the appropriate federal and state bank regulators an application to merge the bank subsidiaries. The resulting bank Board of Directors and executive officers will be the Board of Directors and senior management team of Glacier Bancorp. The consolidation is expected to be completed in early second quarter of 2012, following regulatory approvals.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Correct: Buying Warner Chilcott plc (WCRX) Seen as Takeover Defense by Actavis (ACT)
- Quest (DGX) Acquires Concentra Assets; Enters Long-Term Agreement
- BioLineRx (BLRX) Enters $20M ATM Offering w/ Stifel
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

